A decade ago, "seeing a doctor" meant a waiting room. Today weight loss medication, therapy, hair loss treatment, hormone care and birth control are routinely handled through an app. A small group of strong podcasts tracks how healthcare moved online and who profits. The grid below matches show to question, and the briefing at the end gets you up to speed in three episodes.
Three forces that pushed care online
The pandemic opened the door; three forces pushed the industry through it. The first was GLP-1 weight loss drugs, which created consumer demand on a scale traditional clinics couldn't absorb (we cover what top health podcasts say about GLP-1 drugs in a separate guide). Online prescribers became major distribution channels, and compounded copies were legal while the drugs sat on the FDA's shortage list. Once the agency declared the tirzepatide and semaglutide shortages resolved (December 2024 and February 2025), the drugmakers went after the compounders in one of healthcare's defining business battles.
The second was mental health. Demand outran the supply of in-person therapists and pushed therapy onto platforms, a shift podcasts about therapy and finding help online follow from the patient's side. The growing pains were public: aggressive ADHD prescribing at the startup Cerebral, and the FTC's multimillion-dollar action against BetterHelp for sharing user health data with advertisers.
The third was habit. A generation that manages everything by phone expected healthcare to follow, and men, historically the least likely to book appointments, proved willing patients once the door was a questionnaire about hair, erectile dysfunction or testosterone. Our best podcast episodes on hair loss in your 30s and the TRT debate on men's health podcasts show where that leads.
The shows at a glance
| Show | Host | Angle | Best for | Bias to watch |
|---|---|---|---|---|
| The Heart of Healthcare | Halle Tecco, with Michael Esquivel and Steve Kraus | Founder and operator interviews | How virtual-care companies make money | Insiders, often with a company to promote |
| Second Opinion (now Lifers with Christina Farr) | Christina Farr | Reporter turned investor | Skeptical reads on business models, AI and mental health platforms | Farr also invests in health tech |
| Raising Health | a16z Bio + Health partners | Venture capital | Where investors think AI and consumer health are heading | The hosts' firm funds companies in the sector |
| Digital Health Today | Dan Kendall | International and systems-level | Remote monitoring, digital therapeutics, health systems outside the US | Archive only: no new episodes since September 2023 |
The Heart of Healthcare
Halle Tecco founded Rock Health, which bills itself as the first venture fund dedicated to digital health, and later the fertility company Natalist. On The Heart of Healthcare she and fellow health-tech veterans Michael Esquivel and Steve Kraus interview the founders and operators building (and sometimes breaking) the companies that reshape care delivery. They are unusually candid about which startup models are real medicine and which are regulatory arbitrage. For prescribing economics, start with Ro co-founder Zach Reitano ("Healthcare Is a Handmade Luxury Good", June 2024), then Found CEO Sarah Jones Simmer on the Ozempic rush (November 2023).
Second Opinion, now Lifers with Christina Farr
Christina Farr covered health tech for Reuters, Fast Company and CNBC before joining OMERS Ventures in late 2020. Second Opinion began as her newsletter; the podcast launched under that name in June 2024, co-hosted at first with former healthcare CEOs Ash Zenooz and Luba Greenwood, and now runs on the same feed as Lifers with Christina Farr. She brings a reporter's skepticism the space badly needs. Start with Virta Health CEO Sami Inkinen on alternatives to Ozempic (March 2025), "Anyone can build a clinic now. Should they?" (April 2026, on the cash-pay GLP-1 company Medvi), and Pelago CEO Yusuf Sherwani arguing that ChatGPT is already the largest mental health provider in America (July 2026).
Raising Health
The venture capital view comes straight from Raising Health, hosted by Andreessen Horowitz's Bio + Health team: currently general partners Vineeta Agarwala, Julie Yoo and Jorge Conde (Vijay Pande hosted many earlier episodes). It makes the unapologetic bull case, told by the people funding it. On AI entering clinical workflows (scribing, triage, diagnostics), the episode with Ambience CEO Nikhil Buduma (February 2026) and Julie Yoo's conversation with Suchi Saria (July 2026) map the next few years as investors see them. The 2024 three-part series "The Science and Supply of GLP-1s" covers the drug side.
Digital Health Today
Dan Kendall's long-running show is broader and more international than the US-centric names above. It covers remote patient monitoring, digital therapeutics and how other health systems absorb the same technology under different incentives. The main feed, now Digital Health Today 360, stopped adding episodes in September 2023, but the archive still shows the American direct-to-consumer boom as one version of a global story. Reason.fm has no page for the show yet.
Access versus incentives
The optimist case is access. Telehealth reaches people the old system structurally missed: rural patients, workers without sick leave, people priced out of therapy, men who would never book a urologist. For routine, protocol-driven care, the quality evidence is generally reassuring. The skeptic case, pressed hardest on the journalist-led shows, is about incentives. When a company's revenue depends on the prescription being written, the consultation risks becoming a formality. The marketing (podcast ads included, an irony the shows occasionally acknowledge) then manufactures demand like any consumer industry. Each new controversy, whether a prescribing scandal, an FTC action or a compounding ruling, tends to produce the best episodes within a week or two, because the hosts on this beat already know the companies involved.
How direct-to-consumer prescribing platforms differ
The companies these shows dissect, and many of the ones buying ads on podcasts, run on a few distinct models. Asynchronous services review a questionnaire and photos, and a clinician signs off later with no live conversation. Others require a short video or phone visit before any prescription. Some employ their own clinicians, while others route patients to affiliated medical groups that hold the licenses. The pharmacy side varies too. A platform may send the prescription to a pharmacy you choose, run its own mail-order pharmacy, or sell compounded versions of branded drugs. Payment ranges from insurance billing to cash-only subscriptions that bundle the visit and the medication. Before signing up, check whether you can speak to the prescriber, which pharmacy fills the order, whether the drug is FDA approved or compounded, how follow-up and side-effect questions are handled, and how easily you can cancel. The Heart of Healthcare founder interviews explain why companies choose each model.
A three-episode briefing before you use or build a telehealth service
- The business model: The Heart of Healthcare with Ro's Zach Reitano. How a direct-to-consumer prescriber makes money.
- The incentive problem: Lifers with Christina Farr, "Anyone can build a clinic now. Should they?" What separates a durable virtual clinic from a short-term play.
- Where the money is going: Raising Health with Ambience's Nikhil Buduma on AI in clinical workflows.
Patients come away knowing what to ask a platform before handing over a card number; founders get the economics, the regulatory traps and the investor story. Then follow the threads these shows keep returning to: AI moving from paperwork into triage and diagnosis, and the regulatory scramble around it; telehealth companies growing from a single product (hair, ED, weight) into full primary care and chronic disease management; the settlement between drugmakers, compounders and platforms now that the GLP-1 shortages are over; insurers' uneasy relationship with direct-to-consumer prescribing; and consolidation into a handful of category winners.
Related charts on Reason.fm: Medicine, Health & Fitness, and Tech News.
This article looks at how podcasts discuss the topic and is not medical advice. Talk to a doctor or other qualified clinician about your own situation before starting, changing or stopping any treatment.